Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Carotid revascularization · Michigan | Carotid revascularization · Illinois | |
|---|---|---|
| Surgeons, 2024 | 13 | 31 |
| Medicare fee-for-service cases | 961 | 1,439 |
| Growth since 2019 (Medicare FFS) | −9.4%/yr | −3.9%/yr |
| Forecast cases (Medicare FFS) | 870 in 2030 | 1,600 in 2030 |
| Forecast growth | −1.7%/yr to 2030 | +1.8%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.1 | 1.0 |
| Medicare Advantage share | 66% | 47% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 74 | 46 |
| Top 10 surgeons' share | 81% | 49% |
| Surgeons growing | 0 | 5 |
| New since the base year | 0 | 4 |
| Likely to stop billing it | 7 by 2026 | 9 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $6,679 | $2,936 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.